{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:01:16Z","timestamp":1779321676230,"version":"3.51.4"},"reference-count":70,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T00:00:00Z","timestamp":1472601600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008392","name":"Sundhed og Sygdom, Det Frie Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["271-05-0118"],"award-info":[{"award-number":["271-05-0118"]}],"id":[{"id":"10.13039\/100008392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0161570","type":"journal-article","created":{"date-parts":[[2016,8,31]],"date-time":"2016-08-31T18:16:39Z","timestamp":1472667399000},"page":"e0161570","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["A 7-Gene Signature Depicts the Biochemical Profile of Early Prefibrotic Myelofibrosis"],"prefix":"10.1371","volume":"11","author":[{"given":"Vibe","family":"Skov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Burton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mads","family":"Thomassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Stauffer Larsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline H.","family":"Riley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Brinch Madelung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lasse","family":"Kj\u00e6r","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Bondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inger","family":"Stamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mats","family":"Ehinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasmus","family":"Dahl-S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nana","family":"Brochmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karsten","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten K.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole","family":"Weis Bjerrum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torben A.","family":"Kruse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans Carl","family":"Hasselbalch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,8,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1056\/NEJMra063728","article-title":"Mechanisms of disease. The myeloproliferative disorders","volume":"355","author":"PJ Campbell","year":"2006","journal-title":"N Engl J Med"},{"issue":"11","key":"ref2","first-page":"1126","article-title":"Relevance of bone marrow features in the differential diagnosis between essential thrombocythemia and early stage idiopathic myelofibrosis","volume":"85","author":"J Thiele","year":"2000","journal-title":"Haematologica"},{"issue":"3","key":"ref3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s002770000278","article-title":"Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosis","volume":"80","author":"J Thiele","year":"2001","journal-title":"Ann Hematol"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1080\/10428190290021542","article-title":"Early-stage idiopathic (primary) myelofibrosis\u2014current issues of diagnostic features","volume":"43","author":"J Thiele","year":"2002","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"ref5","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1055\/s-2006-942757","article-title":"The impact of clinicopathological studies on staging and survival in essential thrombocythemia, chronic idiopathic myelofibrosis, and polycythemia rubra vera","volume":"32","author":"HM Kvasnicka","year":"2006","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"ref6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1182\/blood-2007-05-091850","article-title":"Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes","volume":"111","author":"BS Wilkins","year":"2008","journal-title":"Blood"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11899-009-0005-6","article-title":"The 2008 WHO diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis","volume":"4","author":"J Thiele","year":"2009","journal-title":"Curr Hematol Malig Rep"},{"issue":"21","key":"ref8","doi-asserted-by":"crossref","first-page":"5710","DOI":"10.1182\/blood-2010-07-293761","article-title":"Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification","volume":"117","author":"J Thiele","year":"2011","journal-title":"Blood"},{"issue":"23","key":"ref9","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1200\/JCO.2010.34.5298","article-title":"Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study","volume":"29","author":"T Barbui","year":"2011","journal-title":"J Clin Oncol"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/leu.2011.258","article-title":"Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria","volume":"26","author":"G Finazzi","year":"2012","journal-title":"Leukemia"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1182\/blood-2012-01-407981","article-title":"Disease characteristics and clinical outcome in young adults with essential thrombocythemia versus early\/prefibrotic primary myelofibrosis","volume":"120","author":"T Barbui","year":"2012","journal-title":"Blood"},{"issue":"2","key":"ref12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/ajh.22241","article-title":"Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia","volume":"87","author":"A Carobbio","year":"2012","journal-title":"Am J Hematol"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1038\/leu.2013.74","article-title":"Problems and pitfalls regarding WHO-defined diagnosis of early\/prefibrotic primary myelofibrosis versus essential thrombocythemia","volume":"27","author":"T Barbui","year":"2013","journal-title":"Leukemia"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13000-015-0269-1","article-title":"Thrombosis in essential thrombocytemia and early\/prefibrotic primary myelofibrosis: the role of the WHO histological diagnosis","volume":"10","author":"S Rupoli","year":"2015","journal-title":"Diagn Pathol"},{"issue":"10","key":"ref15","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.exphem.2009.07.005","article-title":"JAK2(V617F) allele burden discriminates essential thrombocythemia from a subset of prefibrotic-stage primary myelofibrosis","volume":"37","author":"K Hussein","year":"2009","journal-title":"Exp Hematol"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1365-2559.2010.03545.x","article-title":"Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis","volume":"56","author":"M Brousseau","year":"2010","journal-title":"Histopathology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4339","DOI":"10.1158\/1078-0432.CCR-10-1092","article-title":"Transcriptional profiling of Polycythemia Vera identifies gene expression patterns both dependent and independent from the action of JAK2V617F","volume":"16","author":"W Berkofsky-Fessler","year":"2010","journal-title":"Clin Cancer Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1634\/stemcells.2006-0351","article-title":"Molecular Profiling of CD34+ cells in idiopathic myelofibrosis identifies a set of disease-associated genes and reveals the clinical significance of wilms\u2019 tumor gene 1 (WT1)","volume":"25","author":"P Guglielmelli","year":"2007","journal-title":"Stem Cells"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2009-05-224477","article-title":"Class Prediction models of thrombocytosis using genetic biomarkers","volume":"115","author":"DV Gnatenko","year":"2010","journal-title":"Blood"},{"issue":"10","key":"ref20","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1016\/j.leukres.2011.03.013","article-title":"High expression of carcinoembryonic antigen-related cell adhesion molecule (CEACAM) 6 and 8 in primary myelofibrosis","volume":"35","author":"HC Hasselbalch","year":"2011","journal-title":"Leuk Res"},{"issue":"10","key":"ref21","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.3109\/10428194.2013.764417","article-title":"Whole blood transcriptional profiling reveals significant down-regulation of human leukocyte antigen class I and II genes in essential thrombocythemia, polycythemia vera and myelofibrosis","volume":"54","author":"V Skov","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1600-0609.2011.01618.x","article-title":"Whole-blood transcriptional profiling of interferon-inducible genes identifies highly upregulated IFI27 in primary myelofibrosis","volume":"87","author":"V Skov","year":"2011","journal-title":"Eur J Haematol"},{"issue":"9","key":"ref23","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.exphem.2012.05.011","article-title":"Gene expression profiling with principal component analysis depicts the biological continuum from essential thrombocythemia over polycythemia vera to myelofibrosis","volume":"40","author":"V Skov","year":"2012","journal-title":"Exp Hematol"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/10428194.2011.597905","article-title":"Increased gene expression of histone deacetylases in patients with Philadelphia-negative chronic myeloproliferative neoplasms","volume":"53","author":"V Skov","year":"2012","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"e85567","DOI":"10.1371\/journal.pone.0085567","article-title":"Transcriptional Profiling of Whole Blood Identifies a Unique 5-Gene Signature for Myelofibrosis and Imminent Myelofibrosis Transformation","volume":"9","author":"HC Hasselbalch","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"ref26","doi-asserted-by":"crossref","first-page":"e112786","DOI":"10.1371\/journal.pone.0112786","article-title":"Whole blood transcriptional profiling reveals deregulation of oxidative and antioxidative defence genes in myelofibrosis and related neoplasms. potential implications of downregulation of Nrf2 for genomic instability and disease progression","volume":"9","author":"HC Hasselbalch","year":"2014","journal-title":"PLoS One"},{"key":"ref27","article-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue","author":"SH Swerdlow","year":"2008"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","article-title":"Exploration, normalization, and summaries of high density oligonucleotide array probe level data","volume":"4","author":"RA Irizarry","year":"2003","journal-title":"Biostatistics"},{"key":"ref29","first-page":"1","article-title":"Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application","volume":"2","author":"C Li","year":"2001","journal-title":"Genome Biol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrg1272","article-title":"Network biology: understanding the cell's functional organization","volume":"5","author":"AL Barabasi","year":"2004","journal-title":"Nat Rev Genet"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1182\/blood.V89.10.3503","article-title":"Granules of the human neutrophilic polymorphonuclear leukocyte","volume":"89","author":"N Borregaard","year":"1997","journal-title":"Blood"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00062752-200101000-00005","article-title":"Regulation of human neutrophil granule protein expression","volume":"8","author":"N Borregaard","year":"2001","journal-title":"Curr Opin Hematol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1182\/blood-2004-08-3346","article-title":"The transcriptional program of terminal granulocytic differentiation","volume":"105","author":"K Theilgaard-Monch","year":"2005","journal-title":"Blood"},{"key":"ref34","first-page":"25","article-title":"Neutrophil granules in health and disease","volume":"268","author":"M Hager","year":"2010","journal-title":"J Intern Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0092-8674(89)90970-7","article-title":"Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule","volume":"57","author":"S Benchimol","year":"1989","journal-title":"Cell"},{"issue":"7","key":"ref36","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/sj.bjc.6602113","article-title":"CEACAM6 is a determinant of pancreatic adenocarcinoma cellular invasiveness","volume":"91","author":"MS Duxbury","year":"2004","journal-title":"Br J Cancer"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/01.sla.0000154455.86404.e9","article-title":"CEACAM6 is a novel biomarker in pancreatic adenocarcinoma and PanIN lesions","volume":"241","author":"MS Duxbury","year":"2005","journal-title":"Ann Surg"},{"issue":"5","key":"ref38","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ceb.2006.08.008","article-title":"CEACAMs: their role in physiology and pathophys iology","volume":"18","author":"K Kuespert","year":"2006","journal-title":"Curr Opin Cell Biol"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1158\/1078-0432.CCR-07-1363","article-title":"Carcinoembryonic antigen cell adhesion molecule 6 predicts breast cancer recurrence following adjuvant tamoxifen","volume":"14","author":"L Maraqa","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1172\/JCI0214025","article-title":"Human HTm4 is a hematopoietic cell cycle regulator","volume":"109","author":"JL Donato","year":"2002","journal-title":"J Clin Invest"},{"issue":"1\u20132","key":"ref41","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0925-4773(01)00376-8","article-title":"Hemogen is a novel nuclear factor specifically expressed in mouse hematopoietic development and its human homologue EDAG maps to chromosome 9q22, a region containing breakpoints of hematological neoplasms","volume":"104","author":"LV Yang","year":"2001","journal-title":"Mech Dev"},{"issue":"5","key":"ref42","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1182\/blood-2009-07-235341","article-title":"Hemgn is a direct transcriptional target of HOXB4 and induces expansion of murine myeloid progenitor cells","volume":"116","author":"J Jiang","year":"2010","journal-title":"Blood"},{"issue":"10","key":"ref43","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nri910","article-title":"NF-kappaB regulation in the immune system","volume":"2","author":"Q Li","year":"2002","journal-title":"Nat Rev Immunol"},{"issue":"7007","key":"ref44","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature02924","article-title":"NF-kappaB functions as a tumour promoter in inflammation associated cancer","volume":"431","author":"E Pikarsky","year":"2004","journal-title":"Nature"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"239368","DOI":"10.1155\/2012\/239368","article-title":"A key role for NF-\u03baB transcription factor c-Rel in T-lymphocyte-differentiation and effector functions","volume":"2012","author":"A Visekruna","year":"2012","journal-title":"Clin Dev Immunol"},{"issue":"4","key":"ref46","doi-asserted-by":"crossref","first-page":"e35631","DOI":"10.1371\/journal.pone.0035631","article-title":"Evidence that prefibrotic myelofibrosis is aligned along a clinical and biological continuum featuring primary myelofibrosis","volume":"7","author":"G Barosi","year":"2012","journal-title":"PLoS One"},{"issue":"17","key":"ref47","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1056\/NEJM200004273421706","article-title":"Myelofibrosis with myeloid metaplasia","volume":"342","author":"A Tefferi","year":"2000","journal-title":"N Engl J Med"},{"issue":"12","key":"ref48","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1182\/blood.V98.12.3249","article-title":"Diagnostic and clinical relevance of the number of circulating CD34(+) cells in myelofibrosis with myeloid metaplasia","volume":"98","author":"G Barosi","year":"2001","journal-title":"Blood"},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.leukres.2008.06.002","article-title":"Myelofibrosis with myeloid metaplasia: the advanced phase of an untreated disseminated hematological cancer. Time to change our therapeutic attitude with early upfront treatment?","volume":"33","author":"HC Hasselbalch","year":"2009","journal-title":"Leuk Res"},{"issue":"11","key":"ref50","first-page":"4805","article-title":"Constitutive mobilization of CD34+ cells into the peripheral blood in idiopathic myelofibrosis may be due to the action of a number of proteases","volume":"105","author":"M Xu","year":"2005","journal-title":"Blood"},{"issue":"9","key":"ref51","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1182\/blood-2005-09-3826","article-title":"Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders","volume":"107","author":"F Passamonti","year":"2006","journal-title":"Blood"},{"issue":"8","key":"ref52","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1182\/blood-2008-06-158386","article-title":"French INSERM and the European EUMNET Networks on Myelofibrosis.Does primary myelofibrosis involve a defective stem cell niche? From concept to evidence","volume":"112","author":"JJ Lataillade","year":"2008","journal-title":"Blood"},{"issue":"2","key":"ref53","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cytogfr.2013.01.004","article-title":"The role of cytokines in the initiation and progression of myelofibrosis","volume":"24","author":"HC Hasselbalch","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"issue":"14","key":"ref54","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1182\/blood-2011-11-394775","article-title":"Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer","volume":"119","author":"HC Hasselbalch","year":"2012","journal-title":"Blood"},{"issue":"2","key":"ref55","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.leukres.2012.10.020","article-title":"Chronic Inflammation as a Promoter of Mutagenesis in Essential Thrombocythemia, Polycythemia Vera and Myelofibrosis. A Human Inflammation Model for Cancer Development?","volume":"37","author":"HC Hasselbalch","year":"2013","journal-title":"Leuk Res"},{"issue":"2","key":"ref56","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.leukres.2013.07.002","article-title":"A Role of NF-E2 in Chronic Inflammation and Clonal Evolution in Essential Thrombocythemia, Polycythemia Vera and Myelofibrosis?","volume":"38","author":"HC Hasselbalch","year":"2013","journal-title":"Leuk Res"},{"issue":"11","key":"ref57","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.3324\/haematol.2011.055392","article-title":"The JAK2 46\/1 haplotype: a marker of inappropriate myelomonocytic response to cytokine stimulation, leading to increased risk of inflammation, myeloid neoplasm, and impaired defense against infection?","volume":"96","author":"S Hermouet","year":"2011","journal-title":"Haematologica"},{"issue":"11","key":"ref58","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.3324\/haematol.2010.026708","article-title":"Comparison of different criteria for the diagnosis of primary myelofibrosis reveals limited clinical utility for measurement of serum lactate dehydrogenase","volume":"95","author":"PA Beer","year":"2010","journal-title":"Haematologica"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1182\/blood.V58.5.904.904","article-title":"Immunologic abnormalities in myelofibrosis with activation of the complement system","volume":"58","author":"BR Gordon","year":"1981","journal-title":"Blood"},{"issue":"2","key":"ref60","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1600-0609.1984.tb02175.x","article-title":"Red-cell sensitization in myelofibrosis","volume":"32","author":"HC Hasselbalch","year":"1984","journal-title":"Scand J Haematol"},{"issue":"2","key":"ref61","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1600-0609.1985.tb02252.x","article-title":"Circulating immune complexes in myelofibrosis","volume":"34","author":"HC Hasselbalch","year":"1985","journal-title":"Scand J Haematol"},{"key":"ref62","first-page":"567","article-title":"Fagocitosis de complejos inmunes. Interes diagnostica y patogenetico en la mielofibrosis idiopatica","volume":"26","author":"A Ester","year":"1981","journal-title":"Sangre"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2257.1982.tb00073.x","article-title":"A study of the cellular and humoral immune response in patients with myelofibrosis","volume":"4","author":"E Vellenga","year":"1982","journal-title":"Clin Lab Haematol"},{"issue":"4","key":"ref64","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ajh.2830340411","article-title":"Idiopathic myelofibrosis: a clinical study of 80 patients","volume":"34","author":"HC Hasselbalch","year":"1990","journal-title":"Am J Hematol"},{"issue":"9","key":"ref65","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.leukres.2010.05.010","article-title":"Does auto-immunity contribute to anemia in myeloproliferative neoplasms (MPN)-associated myelofibrosis?","volume":"34","author":"G Barosi","year":"2010","journal-title":"Leuk Res"},{"issue":"11","key":"ref66","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.leukres.2013.09.001","article-title":"Increased prevalence of autoimmune phenomena in myelofibrosis: relationship with clinical and morphological characteristics, and with immunoregulatory cytokine patterns","volume":"37","author":"W Barcellini","year":"2013","journal-title":"Leuk Res"},{"issue":"4","key":"ref67","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11899-014-0227-0","article-title":"An immune dysregulation in MPN","volume":"9","author":"G Barosi","year":"2014","journal-title":"Curr Hematol Malig Rep"},{"issue":"10","key":"ref68","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1182\/blood-2013-11-538983","article-title":"Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia","volume":"123","author":"G Rotunno","year":"2014","journal-title":"Blood"},{"issue":"5","key":"ref69","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/leu.2016.12","article-title":"Myeloproliferative neoplasms and inflammation: Whether to target the malignant clone or the inflammatory process or both","volume":"30","author":"S Koschmieder","year":"2016","journal-title":"Leukemia"},{"issue":"1","key":"ref70","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1182\/blood-2012-11-463257","article-title":"Subcellular mislocalization of the transcription factor NF-E2 in erythroid cells discriminates prefibrotic primary myelofibrosis from essential thrombocythemia","volume":"122","author":"K Aumann","year":"2013","journal-title":"Blood"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0161570","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T13:49:14Z","timestamp":1657201754000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0161570"}},"subtitle":[],"editor":[{"given":"Andre","family":"van Wijnen","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,8,31]]},"references-count":70,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0161570","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,31]]}}}